Latest Press Releases

View more news

May 4, 2023

Viz.ai Appoints Hypertrophic Cardiomyopathy Medical Advisory Board to Advance Innovation

Leading experts to shape the future of Viz.ai’s HCM strategy and platform

April 21, 2023

Viz.ai Wins 2023 Gold Edison Award™ for Innovation

Honored for excellence in innovation in AI Assisted Medicine

April 12, 2023

Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of 2023

Only company in healthcare to be recognized for the fourth time

March 29, 2023

Viz.ai Launches Viz™ Trauma Suite to Support Change in Trauma Center Standards

Tailored for trauma care providers to help expedite patient care and improve outcomes

March 21, 2023

Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm

New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms

March 20, 2023

Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022

Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare

March 4, 2023

Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial

Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed therapy for pulmonary embolism

March 2, 2023

Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM)

Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with HCM

February 14, 2023

Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial

Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral hemorrhage

February 8, 2023

Large real-world, multi-center study demonstrates Viz.ai Platform saves critical minutes in stroke care

Study, across 166 facilities in 17 states, finds AI-powered care coordination crucial for acute stroke management

January 12, 2023

Viz.ai Launches AI-Powered Viz™ Vascular Suite

End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease

December 15, 2022

Viz.ai Wins Four Comparably Awards for Best Place to Work

Healthcare technology leader recognized for its culture, diversity, career growth and outlook

November 30, 2022

Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making

New partnership incorporates latest perfusion technology into the Viz.ai platform

November 28, 2022

Viz.ai Appoints Radiology Advisory Board to Advance Innovation

Leading experts to help shape the future of Viz.ai’s radiology strategy and platform

November 28, 2022

Viz.ai Launches AI-powered Viz™ Radiology Suite

Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment

November 18, 2022

Viz Aortic Real-World Evidence

Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value.

November 16, 2022

Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment

Partnership to accelerate enrollment and diversity in neurovascular clinical research.

November 15, 2022

Viz.ai Partners with Illuminate to Improve Quality of Care for Aortic Aneurysm Patients

Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients.

November 10, 2022

New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review

Median size of aneurysms was 5mm, suggesting that AI-powered detection of incidental cerebral aneurysms can improve patient care pathways.

November 4, 2022

Viz.ai Launches AI-Powered Viz™ Cardio Suite

Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals

November 2, 2022

Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform

Partnership delivers critical insights to cardiac care teams for faster patient triage and care.

October 31, 2022

AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System in Treatment of Pulmonary Embolism

AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients with PE

October 25, 2022

Viz.ai Names Jieun Choe Chief Marketing Officer

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief marketing officer (CMO).

September 1, 2022

Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm

Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity.

July 27, 2022

Viz.ai Receives FDA 510(k) Clearance for Viz™ SUBDURAL (SDH)

AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care

July 26, 2022

Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

Viz.ai announced today it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®.

April 7, 2022

Viz.ai Raises $100 Million in Series D Funding, Led by Tiger Global and Insight Partners at $1.2 Billion Valuation

Round will fuel global expansion of AI-driven healthcare platform that accelerates access to life saving treatments

February 24, 2022

Viz.ai Receives FDA 510(k) Clearance for Viz™ ANEURYSM (ANX)

Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM.

February 11, 2022

New Data Presented at ISC 2022 Further Validates Impact of the Viz™ Platform for Intelligent Care Coordination in the Real World

Data from several new studies presented this week at the International Stroke Conference (ISC) further validates the best-in-class sensitivity and specificity of Viz.ai’s intelligent care coordination platform for stroke in real world settings across multiple commercial modules.

February 9, 2022

Viz.ai and TeleSpecialists Announce Strategic Partnership

Viz.ai and TeleSpecialists, LLC have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.

November 17, 2021

Viz.ai Debuts Viz™ ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN 2021

Viz.ai is the leader in AI-powered care coordination and has accelerated the time-to-notification of the treatment team by 73 percent and time-to-treatment by percent. The Viz Platform is now utilized in over 850 hospitals across the U.S. and Europe and touches almost two patients every minute.

November 16, 2021

Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease

Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting more than 8 hours. Viz.ai uses deep learning to identify suspected pulmonary embolism disease in under two minutes.

August 4, 2021

Viz.ai Receives New Technology Add-on Payment (NTAP) Renewal for Stroke AI Software from CMS

Viz.ai, the world leader in AI-driven intelligent care coordination, has received a New Technology Add-on Payment (NTAP) renewal from Centers for Medicare & Medicaid Services (CMS) for its AI-powered stroke triage module, Viz LVO (formerly known as Viz ContaCT).

July 15, 2021

Viz.ai and Avicenna.AI Partner

Viz.ai, the world leader in AI-driven intelligent care coordination, haspartnered with Avicenna.AI, a global leader in artificialintelligence solutions, to enable intelligent care coordination andimprove patient triage of patients suffering from pulmonary embolism (PE) andaortic disease.

June 30, 2021

Viz.ai Receives CE Mark to Bring Life-saving Stroke Care to Europe

Viz.ai has been awarded a CE Mark for its artificial intelligence (AI) powered stroke care software, affirming its conformity with European health, safety and environmental protection standards for products sold within the European Economic Area.

March 19, 2021

New Data on Stroke Care Show the Impact of Viz.ai’s Artificial Intelligence-Powered Platform on Patient Outcomes

Viz.ai today announced new data supporting the use of its technology to coordinate care for acute ischemic stroke, hemorrhagic stroke, and clinical trial recruitment at the 2021 International Stroke Conference. Dr. Ameer E. Hassan of the Valley Baptist Medical Center in Texas presented...

March 17, 2021

Viz.ai Raises $71 Million Series C Round Led by Scale Venture Partners and Insight Partners

Viz.ai today announced that it has raised $71 million in Series C funding, led by Scale Venture Partners and Insight Partners with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures. Viz.ai aims to accelerate expansion...

October 29, 2020

Record Number of Health Systems Choose Viz.ai's AI-Powered Synchronized Stroke Care Solution to Improve Patient Outcomes

WORLD STROKE DAY -Today, on World Stroke Day, many prominent health systems such as Banner Health, Ohio State University Medical Center, Atrium Health, and Piedmont Healthcare are using artificial intelligence (AI) powered synchronized stroke solutions from Viz.ai to expedite care...

October 1, 2020

Viz.ai Wins UCSF's 2020 Digital Health Award for Best New Application of A.I.

A.I. healthcare company, Viz.ai, has won the prestigious UCSF Digital Health Award for Best New Application of A.I. On the heels of receiving the first New Technology Add-on Payment from CMS for an A.I. powered software system, this award further validates the real world benefits Viz.ai...

September 3, 2020

Viz.ai Granted Medicare New Technology Add-on Payment (NTAP)

Viz.ai, the leading AI stroke platform, is the first AI software to receive a Medicare New Technology Add-on Payment, helping hospitals adopt advanced technology to improve stroke care

November 15, 2018

Viz.ai and NICO Corp. Announce Collaboration to Speed Patient Recruitment in the ENRICH Study

NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH).

November 14, 2018

Viz.ai Designated as American Heart Association/American Stroke Association Get With the Guidelines® Compatible Vendor

Viz.ai, Inc., is the first artificial intelligence company recognized as an American Heart Association/American Stroke Association Get with the Guidelines Compatible Vendor